Regarding TREM2, AD-related hypomethylation is not limited to a population in Japan because the donors who were recruited for the study that first reported TREM2 hypomethylation in AD blood and those recruited for this study were from western and middle areas in Japan, respectively [33]. Here, TREM2 is linked to Alzheimer disease.